GH Research PLC (GHRS)
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Address
JOSHUA DAWSON HOUSE
DUBLIN 2, L2 D02 RY95
Founded
2021
Number of Employees
49
Website
http://www.ghres.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)